These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 69018)

  • 21. Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis.
    Ramasamy R; Joseph B; Whittall T
    Immunol Lett; 2017 Mar; 183():79-85. PubMed ID: 28189601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immunity to measles, myelin basic protein, and central nervous system extract in multiple sclerosis. A longitudinal study employing direct buffy coat migration inhibition assays.
    Lisak RP; Zweiman B; Waters D; Korpowski H; Pleasure DE
    Neurology; 1978 Aug; 28(8):798-803. PubMed ID: 567297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
    Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrobulbar neuritis. In vitro evidence of sensitization to myelin basic protein in patients without multiple sclerosis.
    Sheremata W; Younge B; Eylar EH
    Neurology; 1977 Jun; 27(6):557-60. PubMed ID: 559264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
    Sobel RA; Kuchroo VK
    J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.
    Sharma SD; Nag B; Su XM; Green D; Spack E; Clark BR; Sriram S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11465-9. PubMed ID: 1722335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.
    Cross AH; Tuohy VK; Raine CS
    Cell Immunol; 1993 Feb; 146(2):261-9. PubMed ID: 7513616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein.
    Sakai K; Sinha AA; Mitchell DJ; Zamvil SS; Rothbard JB; McDevitt HO; Steinman L
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8608-12. PubMed ID: 2460872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis.
    Heber-Katz E
    Ann N Y Acad Sci; 1995 Jul; 756():283-93. PubMed ID: 7544078
    [No Abstract]   [Full Text] [Related]  

  • 33. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.
    Shelton JB; Potter CW; Carr I
    Br J Cancer; 1975 May; 31(5):528-34. PubMed ID: 50855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of antibody-dependent lymphocyte cytotoxicity against cerebral tissue constituents in multiple sclerosis. Studies with basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
    Frick E; Stickl H
    Acta Neurol Scand; 1982 Jan; 65(1):30-7. PubMed ID: 6175158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.
    Greer JM; Csurhes PA; Cameron KD; McCombe PA; Good MF; Pender MP
    Brain; 1997 Aug; 120 ( Pt 8)():1447-60. PubMed ID: 9278634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of human allergic encephalitogenic peptide on cell-mediated cytotoxicity reactions in patients with multiple sclerosis.
    Møller-Larsen A; Haahr S; Hansen HJ
    J Neuroimmunol; 1987 Jan; 13(3):273-82. PubMed ID: 2432085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis.
    Martin R; Howell MD; Jaraquemada D; Flerlage M; Richert J; Brostoff S; Long EO; McFarlin DE; McFarland HF
    J Exp Med; 1991 Jan; 173(1):19-24. PubMed ID: 1702137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.